Etanercept

clinical grade

BATCH NUMBER: GR206474

272,00 

Therapeutic Etanercept antibody from the biosimilar Benepali® commercial drug

In stock

Product specifications:​

  • Quality Standard clinical-grade
  • Product Concentration 50 mg/mL
  • Volume per vial 80 µL
  • Quantity per vial 4 mg
  • Origin of the commercial drug DE
  • Batch Number GR206474
  • Storage Temperature -80°C
  • Original therapeutic expiry date: 2023.11

Our products are for research use only. The “therapeutic expiration date” implies expiry date for patient administration and is not applicable to the shelf life of the aliquot. Aliquot storage at -86°C ensures fully functional molecules even after the mentioned expiry date.

Product Information:

Evidentic offers repackaged finished pharmaceutical products (e.g RMP/RLD). We refer to the repackaged RMP/RLD products synonymously as drug aliquots or aRMP, or short: aliquots.

We offer batches of original drug aliquots in low-binding Eppendorf tubes for research use only. We provide license-free drug aliquots with long, short or even “negative shelf life” by storing the products at recommended temperatures (either 2-8°C or -80°C) and ensuring fully functional molecules for research purposes.

As ‘raw material’ for the production of drug aliquots, Evidentic sources RMP from the European (EU) market. As a licensed pharmaceutical wholesaler, Evidentic is committed to Good Distribution Practice (GDP) compliance with respect to the procurement, storage and shipment of RMP.
Drug aliquots are manufactured by repackaging RMP in a qualified laboratory. The aliquotation process is performed under a quality and manufacturing agreement between Evidentic and the contract manufacturer. Repackaging of RMP includes the following steps: opening the secondary and primary RMP containers and transferring the specified volumes of RMP into an Eppendorf 0.5 ml low-binding (or similar) tube. If the RMP is a lyophilized powder and not a highly concentrated solution, reconstitute the RMP according to the original manufacturer’s instructions and then aliquot as a highly concentrated solution.
For identification purposes, drug aliquots are labeled with the date of aliquoting, the original lot number of the RMP, the original expiration date of the RMP, the name of the active ingredient (INN), and a unique identification code.
Immediately after aliquoting, drug aliquots are stored at either 2-8 °C or -86 °C for long-term storage. All drug aliquots stored at 2-8 °C are transferred to -86 °C at least two weeks before the expiration date of the original RLD/RMP is reached. Further quality or functional testing are not performed on the drug aliquots.  

Class of molecule

Host cells

Chinese hamster ovary (CHO) mammalian

Prepared from (Reference drug)​

Benepali®

Therapeutic Area

Mechanism of Action (MoA)

The mechanism of action of etanercept is thought to be its competitive inhibition of TNF binding to cell surface TNFR, preventing TNF-mediated cellular responses by rendering TNF biologically inactive. Etanercept may also modulate biologic responses controlled by additional downstream molecules (e.g., cytokines, adhesion molecules, or proteinases) that are induced or regulated by TNF.

Pharmacotherapeutic group​​

Immunosuppressants

List of Excipients​

Sucrose
Sodium chloride
Sodium dihydrogen phosphate monohydrate
Disodium hydrogen phosphate heptahydrate
Water for injections

Batch specific analytical data available

Evidentic’s analytical service includes a comprehensive array of methods to support the drug development process, including, for example, structure, aggregation, degree of isomerization and N-glycans identification of the active pharmaceutical ingredient (API).

Etanercept

BATCH NUMBER: GR206474

Request an individual offer​

+ download a free sample​

1. Choose your(s) method(s) of interest
2. Provide your contact details
3. Send us your request and download a free sample report


Please provide your contact information


send us your inquiry and download a free sample file


More , , , Reference Drugs as Aliquots

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
CD80
,
CD86
Fusion protein
Orencia®
25 mg/mL
yes
5 mg
-80°C
2023.02
223,00 
view product
Max: 10
Min: 2
Step: 1
TNF alpha
Biosimilar
,
Monoclonal Antibody
Amgevita®
50 mg/mL
2 mg
-80°C
2021.12
304,00 
view product
Max: 10
Min: 1
Step: 1
TNF alpha
Biosimilar
,
Monoclonal Antibody
Hulio®
50 mg/mL
2 mg
-80°C
2023.02
304,00 
view product
Max: 10
Min: 1
Step: 1
TNF alpha
Biosimilar
,
Monoclonal Antibody
Hukyndra®
100 mg/mL
2 mg
-80°C
2023.10
354,00 
view product
Max: 10
Min: 1
Step: 1
TNF alpha
Biosimilar
,
Monoclonal Antibody
Yuflyma®
100 mg/mL
4 mg
-80°C
2024.02
354,00 
view product
Max: 10
Min: 1
Step: 1
TNF alpha
Biosimilar
,
Monoclonal Antibody
Idacio®
50 mg/mL
2 mg
-80°C
2023.10
355,00 
view product
Max: 10
Min: 1
Step: 1
TNF alpha
Biosimilar
,
Monoclonal Antibody
Imraldi®
50 mg/mL
2 mg
-80 °C
2023.10
304,00 
view product
Max: 10
Min: 1
Step: 1
TNF alpha
Biosimilar
,
Monoclonal Antibody
Hyrimoz®
50 mg/mL
2 mg
-80°C
2024.06
304,00 
view product
Max: 10
Min: 1
Step: 1
PlGF
,
VEGF-A
,
VEGF-B
Fusion protein
Zaltrap®
25 mg/mL
2 mg
tba
tba
197,00 
view product
Max:
Min: 11
Step: 1
PIGF
,
VEGF-A
Fusion protein
Eylea®
40 mg/mL
0,8 mg
tba
tba
1.293,00 
view product
Max: 5
Min: 3
Step: 1
CD80
,
CD86
Fusion protein
Nulojix®
25 mg/mL
5 mg
-80°C
2025.01
221,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Zirabev®
25 mg/mL
2 mg
tba
tba
200,00 
view product
Max: 50
Min: 11
Step: 1
VEGF-A
Monoclonal Antibody
Oyavas®
25 mg/mL
2 mg
tba
tba
197,00 
view product
Max: 50
Min: 11
Step: 1
VEGF-A
Monoclonal Antibody
Alymsys®
25 mg/mL
2 mg
tba
tba
197,00 
view product
Max: 50
Min: 11
Step: 1
VEGF-A
Monoclonal Antibody
Aybintio®
25 mg/mL
2 mg
tba
tba
197,00 
view product
Max: 50
Min: 11
Step: 1
VEGF-A
Monoclonal Antibody
Abevmy®
25 mg/mL
2 mg
tba
tba
207,00 
view product
Max: 50
Min: 11
Step: 1
VEGF-A
Monoclonal Antibody
Vegzelma®
25 mg/mL
2 mg
tba
tba
198,00 
view product
Max: 50
Min: 11
Step: 1
C5 complement protein
Biosimilar
,
Monoclonal Antibody
Bekemv®
10 mg/mL
3 mg
tba
tba
391,00 
view product
Max: 20
Min: 16
Step: 1
C5 complement protein
Biosimilar
,
Monoclonal Antibody
Epysqli®
10 mg/mL
3 mg
tba
tba
391,00 
view product
Max: 20
Min: 16
Step: 1
EPO receptor
Biosimilar
,
Glycoprotein hormone
Silapo®
40000 IU/mL
5000 IU
-80°C
2022.08
385,00 
view product
Max: 9
Min: 1
Step: 1
TNF alpha
Biosimilar
,
Fusion protein
Erelzi®
50 mg/mL
4 mg
-80°C
2023.04
272,00 
view product
Max: 10
Min: 2
Step: 1
TNF alpha
Fusion protein
Enbrel®
50 mg/mL
6 mg
-80°C
2024.01
259,00 
view product
Max: 10
Min: 2
Step: 1
TNF alpha
Fusion protein
Enbrel®
25 mg/mL
2 mg
-80°C
2019.02
197,00 
view product
Max: 10
Min: 2
Step: 1
TNF alpha
Fusion protein
Enbrel®
50 mg/mL
2 mg
-80°C
2019.04
197,00 
view product
Max: 10
Min: 2
Step: 1
TNF alpha
Fusion protein
Enbrel®
50 mg/mL
2 mg
-80°C
2019.06
197,00 
view product
Max: 10
Min: 2
Step: 1
TNF alpha
Fusion protein
Enbrel®
50 mg/mL
2 mg
-80°C
2019.08
197,00 
view product
Max: 10
Min: 2
Step: 1
TNF alpha
Fusion protein
Enbrel®
25 mg/mL
2 mg
-80°C
2019.12
197,00 
view product
Max: 10
Min: 2
Step: 1
TNF alpha
Fusion protein
Enbrel®
50 mg/mL
2 mg
-80°C
2019.10
197,00 
view product
Max: 10
Min: 2
Step: 1
TNF alpha
Fusion protein
Enbrel®
50 mg/mL
2 mg
-80°C
2020.04
197,00 
view product
Max: 10
Min: 2
Step: 1
TNF alpha
Biosimilar
,
Fusion protein
Nepexto®
50 mg/mL
4 mg
-80 °C
2023.08
272,00 
view product
Max: 10
Min: 2
Step: 1
1 2

Not looking for Etanercept GR206474?

Search our therapeutic molecules product database

Quick Ordering

Find and order your therapeutic molecules through smart filters

Multiple Batches

Up to 10 batches of original drugs for examining batch-to-batch variations

Reduce Costs

Up to 80% less compared to the original pharmaceutical price

Worldwide Shipping

Shipment within days worldwide according to GDP-standards

Precise Quantity​​

Up to 80% less compared to the original pharmaceutical price

Thank you for your interest in our services.

We will respond to you within one working day. You can now download your sample report.